powerpoint presentation definitions and statistic… · ppt file · web viewcardiovascular...

109
Cardiovascular Cardiovascular Epidemiology and Epidemiology and Prevention Prevention Nathan D. Wong, PhD, FACC, Nathan D. Wong, PhD, FACC, FAHA FAHA Professor and Director, Heart Professor and Director, Heart Disease Prevention Program, Disease Prevention Program, Division of Cardiology, Division of Cardiology, University of California, University of California, Irvine Irvine President, American Society of President, American Society of Preventive Cardiology Preventive Cardiology

Upload: vuonghanh

Post on 16-Mar-2018

215 views

Category:

Documents


3 download

TRANSCRIPT

  • Cardiovascular Epidemiology and PreventionNathan D. Wong, PhD, FACC, FAHAProfessor and Director, Heart Disease Prevention Program, Division of Cardiology, University of California, IrvinePresident, American Society of Preventive Cardiology

    *

  • Textbooks

  • Cardiovascular Epidemiology: Definitions, Concepts, Historical Perspectives and Statistics

    *

  • Definitions

    CORONARY ARTERY DISEASE (CAD) or CORONARY HEART DISEASE (CHD) (often broadly referred to as ISCHEMIC HEART DISEASE (IHD): primarily myocardial infarction and sudden coronary death, broader definition may include angina pectoris, atherosclerosis, positive angiogram, and revascularization (perceutaneous coronary interventions, or PCI such as angioplasty and stents)

    CARDIOVASCULAR DISEASE or CVD includes CHD, cerebrovascular disease, peripheral vascular disease, and other cardiac conditions (congenital, arrhythmias, and congestive heart failure)

    *

  • Definitions (cont.)

    SURROGATE MEASURES include: carotid intimal medial thickness (IMT), coronary calcium, angiographic stenosis, brachial ultrasound flow mediated dilatation (FMD)

    Hard endpoints include myocardial infarction, CHD death, and stroke

    *

  • *

    Hospital Specialty_FINAL ATS

    *

    *

  • Source: NCHS and NHLBI. A indicates CVD plus congenital CVD; B, cancer; C, accidents; D, CLRD; E, diabetes; and F, Alzheimer's disease.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

    CVD and other major causes of death for all males and females (United States: 2007).

  • Trends in cardiovascular procedures, United States: 19792009

    Note: Inpatient procedures only. Source: National Hospital Discharge Survey, NCHS, and NHLBI.

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

  • Direct and indirect costs (in billions of dollars)

    of major cardiovascular diseases and stroke (United States: 2008)

    Source: National Heart, Lung, and Blood Institute.

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

  • Projected Total Costs of CVD, 20152030 (in Billions 2008$) in the United States

    Unpublished data tabulated by AHA using methods described in Circulation. 2011;123:933944.

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

  • CVD disease mortality trends for males and females(United States: 1979-2006). Source: NCHS and NHLBI.

    Chart1

    496.676466.361

    506.154487.194

    487.453495.286

    444.763475.482

    452.452503.139

    440.175505.661

    398.563432.709

    Males

    Females

    Years

    Deaths in Thousands

    Sheet1

    CVDCVDCardiovascular Disease Mortality Trends for Males and FemalesCVD *CVD*CVDCVD

    MalesFemalesUnited States: 1979-2006MalesFemalesMalesFemales

    795004697949746679497466

    805104908050648780506487

    8150048449748185487495

    8249548449248190445475

    8349849449549195452503

    8449149348749100440506

    854914988548749506399433

    86481498478495

    87475499472496

    88476504473501

    89456486453483

    9044847890445475

    91447479444477

    92444479441477

    93457500454498

    94452498449496

    9545550595452503

    96453506451504

    97450503448501

    98446504Actual MortalityAdjusted Mortality*443502

    99446513adjusted by 9-10 comparability ratio. (0.9981)445.024511.929446513

    00440506440.175505.661439.339504.70000440506

    01432499432.245498.863431.424497.915432499

    Source: Final mortality data, NCHS.433.827493.69002433.003492.752434494

    Numbers are in thousands.427.891483.37203427.078482.454428483

    CVD including congenital CV disease.410.365461.15204409.585460.276411459

    05410455

    * - Since comparability ratio is so close to 1.00

    it is not necessary to adjust. As per TT 9/26/06.

    Sheet1

    Males

    Females

    Years

    Deaths in Thousands

  • Hospital discharges for cardiovascular diseases. (United States: 1970-2006). Note: Hospital discharges include people discharged alive, dead and status unknown. Source: NCHS and NHLBI.

    Chart1

    3.34

    4.418

    5.14

    5.47

    5.161

    5.83

    6.294

    6.161

    Years

    Discharges in Millions

    CVD

    CVD (390-459)Hdis.MalesFemalesHospital Discharges* for Cardiovascular Diseases as First listed Diagnosis

    703.34United States: 1970-2006

    3.543

    3.86

    4.11

    4.304

    754.418

    4.585

    4.758

    4.766

    4.907792.4712.436

    805.14802.592.549

    5.336812.6792.657

    5.4882.7852.703

    5.6542.8962.758

    5.5932.8562.737

    855.47852.7832.686

    5.5632.8462.717

    5.5722.8682.704

    5.2962.7222.574

    5.1972.672.527

    905.161902.6682.493

    5.3382.7282.611703.34

    5.5972.8662.73754.418

    5.6332.8852.747805.14

    5.7792.9062.873855.47

    955.83952.9732.857905.161

    6.1073.1013.006955.83

    6.0973.1163.03006.294

    6.272983.1393.133066.161

    6.344794.907

    006.2943.1153.179805.14

    6.2263.0583.168815.336

    6.3733.2093.164825.488

    6.4343,2393.196835.654

    6.3633.2273.136845.593

    056.1593.1363.023855.47

    066.1613.1213.04865.563

    875.572

    885.296

    895.197

    905.161

    915.338

    925.597

    935.633

    945.779

    955.83

    966.107

    976.097

    NOTE: do not include congenital!986.272

    996.344

    006.294

    Neoplams 140-4591.61.631

    Endocrine System 240-2791.71.663

    Musculoskeletal System 710-7392.01.969

    Genitourinary System 580-6292.01.974

    Mental 290-3192.42.419

    External: Injuries, etc. 800-9993.02.968

    Respiratory System 460-5193.53.485

    Digestive System 520-5793.53.517

    Obstetrical V274.14.127

    Cardiovascular 340-4596.26.161

    Chart 2-20. Hospital Discharges for the 10 Leading Diagnostic Groups

    United States: 2006

    &A

    Page &P

    CVD

    0

    0

    0

    0

    0

    0

    0

    0

    Years

    Discharges in Millions

    stroke

    Hospital Discharges Where Stroke Was the First Listed Diagnosis

    United States: 1979 to Date

    YearMalesFemalesTotal

    79335411746

    80371425796

    368439807

    388446834

    407469876

    420477897

    85407499906

    398491889

    392503895

    336448784

    344447791

    90355453808

    371464835

    376450826

    387452839

    407478885

    95424501925

    438518956

    4615551017

    4575531010

    434527961

    00428553981

    391539931

    432509942

    455510965

    416490906

    05418477895

    06404486889

    Hospital Discharges Where Stroke Was the First Listed Diagnosis

    United States: 1979-2006

    &A

    Page &P

    stroke

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    Males

    Females

    Years

    Discharges in Thousands

    CHF

    Hospital Discharges for CHF

    CHF Discharges

    -----------In thousands------

    MalesFemalesTotal

    708074155

    7986165

    98102200

    107111218

    121113234

    75122131253

    123143267

    143152296

    157173330

    174203377

    80176224401

    182240423

    195243439

    208255464

    228303531

    85247310557

    274308582

    269336605

    277357634

    304339643

    90315386701

    360405764

    373449822

    394481875

    390484874

    95378494872

    377493870

    431526957

    438540978

    430532962

    00418581999

    444551995

    441529970

    4715661,037

    04

    Hospital Discharges*for Congestive Heart Failure by Sex

    United States: 1970-2003

    &A

    Page &P

    CHF

    1

    &A

    Page &P

    #REF!

    Discharges in Millions

    HF

    Hospital Discharge Code=428 FL (1970-2003) Heart Failure

    MaleFemale

    197011,07111,238

    9,5199,157

    10,4909,276

    9,42910,090

    8,9249,555

    7510,3259,056

    7,4888,974

    6,2617,660

    5,3346,539

    MaleFemale

    79185214

    80190240

    195252

    207257Hospital discharges for Heart Failure by Sex

    221276United States: 1979-2006MaleFemale

    23731779185214

    8525932680190240

    28732885259326

    28234790325397

    28937595384497

    31235100422586

    9032539706523583

    370417

    384456

    404491

    395492

    95384497

    381496

    436530

    442547

    434541

    00422586

    446554

    443530

    496597

    05494590

    06523583

    Males

    Females

    Years

    Discharges in Thousands

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    HF

    00

    00

    00

    00

    00

    00

    00

    Male

    Female

    Years

    Discharges in Thousands

    HBP

    Hospital Discharges Where HBP Was the First-Listed DiagnosisHospital Discharges Where HBP Was the All-Listed Diagnosis

    United States: 1979 to Date (000)United States: 1979 to Date (000)

    MalesFemalesTotalMalesFemalesTotal

    19901221642851990163422303864

    129190317178625204305

    9215321336792200427834788

    176208383223230235255

    9415122137394234832505599

    174200384244133605807

    9617124641796262535486178

    173250422277838596639

    9817126643798295041967146

    172267439319844367640

    0018627145700330247328043

    194292486396854059375

    0222431253502396854059375

    221299520424056419885

    04230322551044500596510473

    05215284499054648599910653

    First-Listed Hospital Discharges for Hypertension by SexAll-Listed Hospital Discharges for Hypertension by Sex

    United States 1990-2005United States 1990-2005

    HBP

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    Males

    Females

    Years

    Discharges in Thousands

    chd

    Hospital Discharges Where CHD Was the First Listed Diagnosis

    United States: 1979-2000

    (000)(000)

    YearMalesFemales

    70779597

    851628

    935693

    982725

    1030756

    751043789

    1087843

    1111852

    1110844

    10147241738

    801049737

    1095765

    1160841

    1229852

    1044840

    851205846

    1250889

    1268901

    1220830

    1174819

    901151795

    1146806

    1247886

    1205872

    1219899

    9512698582127

    1325933

    1249840

    1263915

    1317945

    001274892

    1199891

    1249875

    1175834

    11808011981

    0511177111828

    0610567041760

    Hospital Discharges for Coronary Heart Diasease by SexYearMalesFemales

    United States: 1970-200670779597

    751043789

    801107795

    851226864sent by Maria Owings 9/19/08

    901159806

    951271865

    001277896

    061056706

    Males

    Females

    Years

    Discharges in Thousands

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    &A

    Page &P

    chd

    00

    00

    00

    00

    00

    00

    00

    00

    Males

    Females

    Years

    Discharges in Thousands

    2

    2

    2.4

    3.5

    4.1

    6.2

    3

    1.7

    1.6

    3.5

    01234567

    Neoplams 140-459

    Endocrine System 240-279

    Musculoskeletal System 710-739

    Genitourinary System 580-629

    Mental 290-319

    External: Injuries, etc. 800-999

    Respiratory System 460-519

    Digestive System 520-579

    Obstetrical V27

    Cardiovascular 340-459

    Discharges in Millions

    MBD0012E4D4.xls

    Chart9

    1.6

    1.7

    2

    2

    2.4

    3

    3.5

    3.5

    4.1

    6.2

    Discharges in Millions

    Sheet1

    Neoplams 140-4591.61.631

    Endocrine System 240-2791.71.663

    Musculoskeletal System 710-7392.01.969

    Genitourinary System 580-6292.01.974

    Mental 290-3192.42.419

    External: Injuries, etc. 800-9993.02.968

    Respiratory System 460-5193.53.485

    Digestive System 520-5793.53.517

    Obstetrical V274.14.127

    Cardiovascular 340-4596.26.161

    Chart 2-20. Hospital Discharges for the 10 Leading Diagnostic Groups

    United States: 2006

    Hemic and Lymphatic 40-410.40.371

    Urinary System 55-591.01.025

    Nervous System 01-051.21.155

    Respiratory System 30-341.21.167

    Integumentary System 85-861.61.598

    Female Genital Organs 65-712.01.957

    Musculoskeletal 76-844.24.188

    Digestive System 42-545.65.571

    Cardiovascular 35-396.56.491

    Obstetrical 72-757.17.076

    Chart 18-3. Number of Surgical Procedures in the 10 Leading Diagnostic Groups

    United States: 2006

    Sheet1

    1.6

    1.7

    2

    2

    2.4

    3

    3.5

    3.5

    4.1

    6.2

    Discharges in Millions

    Sheet2

    Millions of Discharges

    Hemic and Lymphatic 40-41

    Urinary System 55-59

    Nervous System 01-05

    Respiratory System 30-34

    Integumentary System 85-86

    Female Genital Organs 65-71

    Musculoskeletal 76-84

    Digestive System 42-54

    Cardiovascular 35-39

    Obstetrical 72-75

    0.4

    1

    1.2

    1.2

    1.6

    2

    4.2

    5.6

    6.5

    7.1

    Sheet3

    *

  • Source: NCHS and NHLBI. These data include CHD, HF, stroke, and hypertension.

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Prevalence of CVD in adults 20 years of age by age and sex (NHANES: 20052008)

  • 2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Deaths due to diseases of the heart (United States: 19002008)

    Source: National Center for Health Statistics.

  • CVD deaths vs. cancer deaths by age.

    (United States: 2006). Source: NCHS.

    Chart1

    25.05720.577

    47.83950.334

    81.456101.454

    119.809137.554

    241.95164.889

    315.1685.08

    831.272559.888

    CVD

    Cancer

    Ages

    Deaths in Thousands

    Sheet1

    CVD/can/age 2006 Final

    CVDCancer

  • Source: NCHS and NHLBI. A indicates CVD plus congenital CVD; B, cancer; C, accidents; D, CLRD; E, diabetes; and F, Alzheimer's disease.

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    CVD and other major causes of death for all males and females (United States: 2008)

  • Source: NCHS and NHLBI.

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Prevalence of stroke by age and sex (NHANES: 20052008)

  • Prevalence of stroke by age and sex (NHANES: 20052008).

    Source: NCHS and NHLBI.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

  • Percentage breakdown of deaths from cardiovascular diseases (United States: 2006) * - Not a true underlying cause.Source: NCHS.

    Chart1

    51

    17

    7

    7

    4

    14

    PieCVD

    2003CVD total mortality2004 CVD total mortality final2006 CVD total mortality

    910,614PreliminaryPercentage Breakdown of Deaths From Cardiovascular DiseasesPercentage Breakdown of Deaths From Cardiovascular Diseases

    479,304CHD52.6Coronary Heart Disease52451,32652United States:2004Coronary Heart Disease51425,42551.4United States:2006

    157,803Stroke17.3Stroke17150,07417Stroke17137,11916.6

    57,218HF6.3HF757,1207HF*760,3377.3

    52,604Hyp.5.8High Blood Pressure654,7076High Blood Pressure756,5616.8

    37,647Dis. of Arteries4.1Diseases of the Arteries435,5544Diseases of the Arteries431,1363.8

    4,178Cong.HD0.5Congenital Cardiovascular Defects0.43,8610.4Other14117,16314.2

    3,554RF/RHD0.4Rheumatic Fever/Rheumatic Heart Disease0.43,2540.4827,741100.0

    118,306Other13.0Other13113,82813

    910614100.0869724100.0

    Note - CHD is 52 not 53.

    Note: Try to arrange in descending order.

    * Not a true underlying cause.

    NOTE: May not add to 100 due to rounding.

    Does not include congenital.

    959,368Percentage Breakdown of Deaths From Cardiovascular Diseases

    529659CHD55.2Coronary Heart Disease54502,18954United States:1980

    167,366Stroke17.4Stroke18163,53818

    54,920CHF38.9Congestive Heart Failure652,8286

    42,997Hyp.4.5High Blood Pressure546,7655

    14,979Dis. of Arteries1.6Diseases of the Arteries439,4044

    3,676RF/RHD0.4Rheumatic Fever/Rheumatic Heart Disease0.43,4890.4

    4657Cong.HD0.5Congenital Cardiovascular Defects0.44,1090.4

    141114Other15.5Other13118,78613

    959368134.0100.8931,108100.0

    1990 CVD total mortality1990CVD total mortality

    959,368Percentage Breakdown of Deaths From Cardiovascular Diseases

    529659CHD55.2Coronary Heart Disease54502,18954United States:1990

    167,366Stroke17.4Stroke18163,53818

    54,920CHF38.9Congestive Heart Failure652,8286

    42,997Hyp.4.5High Blood Pressure546,7655

    14,979Dis. of Arteries1.6Diseases of the Arteries439,4044

    3,676RF/RHD0.4Rheumatic Fever/Rheumatic Heart Disease0.43,4890.4

    4657Cong.HD0.5Congenital Cardiovascular Defects0.44,1090.4

    141114Other15.5Other13118,78613

    959368134.0100.8931,108100.0

    &A

    Page &P

    PieCVD

    53%

    LCDAIAN

    LCD AM. INDIAN M/F, 2003

    Diseases of the Heart and Stroke and other Major Causes of Death for American Indian/Alaska Native Males and Femlaes

    MALESFEMALESUnited States: 2003

    Diseases of the Heart, and StrokeA24.9Diseases of the Heart, and StrokeA24.7

    CancerB15.4CancerB17.6

    AccidentsC14.7AccidentsC8.8

    Diabetes MellitusD5.2DiabetesD6.9

    Chronic Liver Disease and CirrhosisE4.5Chronic Liver Disease and CirrhosisE4.2

    Diseases of the Heart and Stroke and other Major Causes of Death for American Indian/Alaska Native Males and Femlaes

    United States: 2003

    Females

    Males

    MALES

    Diseases of the Heart, and Stroke23.6FEMALES

    Cancer17.4Diseases of the Heart, and Stroke25.0

    Accidents14.2Cancer19.2

    Diabetes Mellitus5.1Accidents8.5

    Chronic Liver Disease and Cirrhosis4.5Diabetes Mellitus6.4

    Chronic Liver Disease and Cirrhosis4.2

    Diseases of the Heart and Stroke and other Major Causes of Death for American Indian/Alaska Native Males and FemlaesDiseases of the Heart and Stroke and other Major Causes of Death for American Indian/Alaska Native Males and Femlaes

    United States: 2004United States: 2004

    MALESFEMALES

    CVD (I00-I99)A24.4CVD (I00-I99)A25.8

    CancerB16.0CancerB19.2

    AccidentsC15.5AccidentsC8.1

    Diabetes MellitusD4.7DiabetesD7.0

    Chronic Liver Disease and CirrhosisE4.3CLRDF4.3

    ABCDEABCDF

    Males24.416.015.54.74.3

    Females25.819.28.17.04.3

    CVD and Other Major Causes of Death for American Indian or Alaska Native Males and Females

    United States: 2006

    &A

    Page &P

    LCDAIAN

    MALES

    Percent of Total Deaths

    LCDWHITEMF

    CVD and Other Major Causes of Death for White Females

    LCD WHITE M/F, 2004 finalUnited States: 2004

    10072661049377

    MALESFEMALES

    CVD+cong.A35.1CVD+cong.A37.7

    CancerB24.6CancerB22.0

    AccidentsC6.1Chronic LRDD5.7

    Chronic LRDD5.3Alzheimer'sF4.1

    DiabetesE2.8AccidentsC3.3

    CVD and Other Major Causes of Death for White Males

    United States:2004

    Females

    Males

    LCD WHITE M/F, 2006

    MALESFEMALES

    CVD+cong.A33.3CVD+cong.A35.3

    CancerB24.5CancerB22.0

    AccidentsC6.5Chronic LRDD5.8

    Chronic LRDD5.3Alzheimer'sF4.5

    DiabetesE2.8AccidentsC3.5

    ABCDEABDFC

    Males33.324.56.55.32.8

    Females35.322.05.84.53.5

    CVD and Other Major Causes of Death for White Males and Females

    United States:2006

    `

    FEMALES

    Percent of Total Deaths

    Percent of Total Deaths

    Percent of Total Deaths

    Males

    Females

    Percent of Total Deaths

    &A

    Page &P

    LCDWHITEMF

    MALES

    Percent of Total Deaths

    LCDMF

    LCD MALES AND FEMALES, 2004 (Final)CVD and Other Major Causes of Death for All Males and Females

    United States: 2004

    MALESFEMALES

    CVD+cong.A410,628CVD+cong.A459,096

    CancerB286,830CancerB267,058

    AccidentsC72,050Chronic LRDD63,341

    Chronic LRDD58,646Alzheimer'sF46,991

    DiabetesE35,267DiabetesE37,871

    CVD and Other Major Causes of Death for All Males and Females

    United States: 2004

    Females

    Males

    LCD, 2002

    Total CVD433,825

    Cancer288,768

    Accidents69,257

    Chronic Lower Respiratory Disease60,713

    Diabetes Mellitus34,301

    Leading Causes of Death

    United States: 2002

    LCD MALES AND FEMALES, 2005

    MALESFEMALES

    CVD+cong.A398,563CVD+cong.A432,709

    CancerB290,069CancerB269,819

    AccidentsC78,941Chronic LRDD65,323

    Chronic LRDD59,260Alzheimer'sF51,281

    DiabetesE36,006AccidentsC42,658

    ABCDEABDFC

    Males398,563290,06978,94159,26036,006

    Females432,709269,81965,32351,28142,658

    CVD and Other Major Causes of Death for All Males and Females

    United States: 2006

    FEMALES

    Percent of Total Deaths

    Males

    Females

    Percent of Total Deaths

    &A

    Page &P

    LCDMF

    MALES

    Deaths in Thousands

    LCDBLKMF

    LCD BLACK M/F, 2004 final

    CVD and Other Major Causes of Death for Black Males and Females

    MALESFEMALESUnited States: 2004

    CVD+cong.A32.9CVD+cong.A38.1

    CancerB22.2CancerB21.3

    AccidentsC5.9DiabetesE5.1

    Assault(Homicide)D4.7Nephritis, etc.F3.0

    DiabetesE3.8AccidentsC2.9

    CVD and Other Major Causes of Death for Black Males and Females

    United States: 2004

    Females

    Males

    LCD BLACK M/F, 2006

    MALESFEMALES

    CVD+cong.A32.3CVD+cong.A35.9

    CancerB21.9CancerB21.6

    AccidentsC6.5DiabetesE5.0

    Assault(Homicide)D5.2Nephritis, etc.F3.2

    DiabetesE3.9AccidentsC3.1

    ABCDEABEFC

    Males32.321.96.55.23.9

    Females35.921.65.03.23.1

    CVD and Other Major Causes of Death for Black Males and Females

    United States: 2006

    FEMALES

    Deaths in Thousands

    Deaths in Thousands

    Males

    Females

    Deaths

    &A

    Page &P

    LCDBLKMF

    MALES

    Percent of Total Deaths

    LCDAPI

    MalesFemales

    Diseases of Heart and StrokeA34.0Diseases of Heart and StrokeA34.7

    CancerB25.5CancerB27.1

    AccidentsC5.6AccidentsC4.1

    Chronic Lower Respiratory DiseaseD3.8Diabetes MellitusE3.9

    DiabetesE3.3Influenza and PneumoniaF3.0

    Diseases of the Heart and Stroke and Other Major Causes of Death for Asian/Pacific Islander Males and FemalesDiseases of the Heart and Stroke and Other Major Causes of Death for Asian/Pacific Islander Males and Females

    United States: 2003United States: 2003

    MalesFemales

    Diseases of Heart and Stroke34.7

    Diseases of Heart and Stroke32.9Cancer27.1

    Cancer26.7Accidents4.1

    Accidents5.5Diabetes Mellitus3.9

    Chronic Lower Respiratory Disease3.5Influenza and Pneumonia3.0

    Diabetes Mellitus3.3

    Diseases of the Heart and Stroke and Other Major Causes of Death for Asian/Pacific Islander Males and Females

    Diseases of the Heart and Stroke and Other Major Causes of Death for Asian/Pacific Islander Males and FemalesUnited States: 2003

    United States: 2004

    MalesFemales

    MalesFemales

    CVD (I00-I99)A34.5CVD (I00-I99)A34.8

    CancerB25.5CancerB27.2

    AccidentsC5.6AccidentsC3.8

    Chronic Lower Respiratory DiseaseD3.6Diabetes MellitusE3.8

    DiabetesE3.5Influenza and PneumoniaF3.0

    ABCDEABCEF

    Males34.525.55.63.63.5

    Females34.827.23.83.83.0

    CVD and Other Major Causes of Death for Asian/Pacific Islander Males and Females

    United States: 2006

    FEMALES

    Percent of Total Deaths

    Males

    Females

    Percent of Total Deaths

    LCDAPI

    Females

    Percent of Total Deaths

    lcdkids

    LCD MALE AND FEMALE Children Age

  • Prevalence of heart failure by age and sex (NHANES: 2005-2006). Source: NCHS and NHLBI.

    Chart1

    0.10.2

    2.21.2

    9.34.8

    13.812.2

    Men

    Women

    Percent of Population

    DEATHSCHF

    Deaths From CHF, United States: 1979-98 (428.0)

    (000)Congestive

    Ht. Failuremalesfemaleswmwfbmbf

    197920

    8022

    8123

    8225

    83271116101411411712511573

    84291217109011532913031708

    85321319114801684914181841

    86341420124511812714591989

    87351421125571916114661949

    88371522132872014115672109

    89341321119031870014082056

    90341321118251871613971931

    91351422121191963713331999

    92361422124682030013351963

    93421626142322351814772246

    94421626141492354614192119

    95431627145952436714652217

    96441727

    97451728

    98471829comp. Ratio

    9951193248,8221.041

    0052193249,516

    0153203350,747

    Deaths From Congestive Heart Failure

    United States: 1979-97

    &A

    Page &P

    DEATHSCHF

    Congestive Ht. Failure

    Years

    Deaths in Thousands

    PCTCHGCHF

    Congestive Heart Failure % Increase in Deaths

    CHF

    7919.936

    8021.804

    8123.297

    8225.09

    8327.274

    8429.429

    8531.807

    8634.271

    8735.387

    8837.371

    8934.348

    9034.156

    9135.393

    9236.387

    9341.819

    9441.601

    9543.01

    9643.837

    119.8886436597

    &A

    Page &P

    HFPREV

    HF PREVALENCE

    MenWomen

    20-390.10.2

    40-592.21.2

    60-799.34.8

    80+13.812.2

    Prevalence of Heart Failure by Age and Sex

    United States: 2005-2006

    &A

    Page &P

    HFPREV

    Men

    Women

    Percent of Population

    *

  • Note: Hospital discharges include people discharged alive, dead and status unknown.

    Hospital discharges for heart failure by sex.

    (United States: 1979-2006). Source: NHDS/NCHS and NHLBI.

    Chart1

    185.303214.49

    190.125240.37

    258.645326.377

    324.63397.288

    383.917496.515

    421.896585.791

    523583

    Male

    Female

    Years

    Discharges in Thousands

    CVD

    CVD (390-459)Hdis.MalesFemalesHospital Discharges* for Cardiovascular Diseases as First listed Diagnosis

    703.34United States: 1970-2006

    3.543

    3.86

    4.11

    4.304

    754.418

    4.585

    4.758

    4.766

    4.907792.4712.436

    805.14802.592.549

    5.336812.6792.657

    5.4882.7852.703

    5.6542.8962.758

    5.5932.8562.737

    855.47852.7832.686

    5.5632.8462.717

    5.5722.8682.704

    5.2962.7222.574

    5.1972.672.527

    905.161902.6682.493

    5.3382.7282.611703.34

    5.5972.8662.73754.418

    5.6332.8852.747805.14

    5.7792.9062.873855.47

    955.83952.9732.857905.161

    6.1073.1013.006955.83

    6.0973.1163.03006.294

    6.272983.1393.133066.161

    6.344794.907

    006.2943.1153.179805.14

    6.2263.0583.168815.336

    6.3733.2093.164825.488

    6.4343,2393.196835.654

    6.3633.2273.136845.593

    056.1593.1363.023855.47

    066.1613.1213.04865.563

    875.572

    885.296

    895.197

    905.161

    915.338

    925.597

    935.633

    945.779

    955.83

    966.107

    976.097

    NOTE: do not include congenital!986.272

    996.344

    006.294

    Neoplams 140-4591.61.631

    Endocrine System 240-2791.71.663

    Musculoskeletal System 710-7392.01.969

    Genitourinary System 580-6292.01.974

    Mental 290-3192.42.419

    External: Injuries, etc. 800-9993.02.968

    Respiratory System 460-5193.53.485

    Digestive System 520-5793.53.517

    Obstetrical V274.14.127

    Cardiovascular 340-4596.26.161

    Chart 2-20. Hospital Discharges for the 10 Leading Diagnostic Groups

    United States: 2006

    &A

    Page &P

    CVD

    0

    0

    0

    0

    0

    0

    0

    0

    Years

    Discharges in Millions

    stroke

    Hospital Discharges Where Stroke Was the First Listed Diagnosis

    United States: 1979 to Date

    YearMalesFemalesTotal

    79335411746

    80371425796

    368439807

    388446834

    407469876

    420477897

    85407499906

    398491889

    392503895

    336448784

    344447791

    90355453808

    371464835

    376450826

    387452839

    407478885

    95424501925

    438518956

    4615551017

    4575531010

    434527961

    00428553981

    391539931

    432509942

    455510965

    416490906

    05418477895

    06404486889

    Hospital Discharges Where Stroke Was the First Listed Diagnosis

    United States: 1979-2006

    &A

    Page &P

    stroke

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    Males

    Females

    Years

    Discharges in Thousands

    CHF

    Hospital Discharges for CHF

    CHF Discharges

    -----------In thousands------

    MalesFemalesTotal

    708074155

    7986165

    98102200

    107111218

    121113234

    75122131253

    123143267

    143152296

    157173330

    174203377

    80176224401

    182240423

    195243439

    208255464

    228303531

    85247310557

    274308582

    269336605

    277357634

    304339643

    90315386701

    360405764

    373449822

    394481875

    390484874

    95378494872

    377493870

    431526957

    438540978

    430532962

    00418581999

    444551995

    441529970

    4715661,037

    04

    Hospital Discharges*for Congestive Heart Failure by Sex

    United States: 1970-2003

    &A

    Page &P

    CHF

    1

    &A

    Page &P

    #REF!

    Discharges in Millions

    HF

    Hospital Discharge Code=428 FL (1970-2003) Heart Failure

    MaleFemale

    197011,07111,238

    9,5199,157

    10,4909,276

    9,42910,090

    8,9249,555

    7510,3259,056

    7,4888,974

    6,2617,660

    5,3346,539

    MaleFemale

    79185214

    80190240

    195252

    207257Hospital discharges for Heart Failure by Sex

    221276United States: 1979-2006MaleFemale

    23731779185214

    8525932680190240

    28732885259326

    28234790325397

    28937595384497

    31235100422586

    9032539706523583

    370417

    384456

    404491

    395492

    95384497

    381496

    436530

    442547

    434541

    00422586

    446554

    443530

    496597

    05494590

    06523583

    Males

    Females

    Years

    Discharges in Thousands

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    HF

    00

    00

    00

    00

    00

    00

    00

    Male

    Female

    Years

    Discharges in Thousands

    HBP

    Hospital Discharges Where HBP Was the First-Listed DiagnosisHospital Discharges Where HBP Was the All-Listed Diagnosis

    United States: 1979 to Date (000)United States: 1979 to Date (000)

    MalesFemalesTotalMalesFemalesTotal

    19901221642851990163422303864

    129190317178625204305

    9215321336792200427834788

    176208383223230235255

    9415122137394234832505599

    174200384244133605807

    9617124641796262535486178

    173250422277838596639

    9817126643798295041967146

    172267439319844367640

    0018627145700330247328043

    194292486396854059375

    0222431253502396854059375

    221299520424056419885

    04230322551044500596510473

    05215284499054648599910653

    First-Listed Hospital Discharges for Hypertension by SexAll-Listed Hospital Discharges for Hypertension by Sex

    United States 1990-2005United States 1990-2005

    HBP

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    Males

    Females

    Years

    Discharges in Thousands

    chd

    Hospital Discharges Where CHD Was the First Listed Diagnosis

    United States: 1979-2000

    (000)(000)

    YearMalesFemales

    70779597

    851628

    935693

    982725

    1030756

    751043789

    1087843

    1111852

    1110844

    10147241738

    801049737

    1095765

    1160841

    1229852

    1044840

    851205846

    1250889

    1268901

    1220830

    1174819

    901151795

    1146806

    1247886

    1205872

    1219899

    9512698582127

    1325933

    1249840

    1263915

    1317945

    001274892

    1199891

    1249875

    1175834

    11808011981

    0511177111828

    0610567041760

    Hospital Discharges for Coronary Heart Diasease by SexYearMalesFemales

    United States: 1970-200670779597

    751043789

    801107795

    851226864sent by Maria Owings 9/19/08

    901159806

    951271865

    001277896

    061056706

    Males

    Females

    Years

    Discharges in Thousands

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    &A

    Page &P

    chd

    00

    00

    00

    00

    00

    00

    00

    00

    Males

    Females

    Years

    Discharges in Thousands

    2

    2

    2.4

    3.5

    4.1

    6.2

    3

    1.7

    1.6

    3.5

    01234567

    Neoplams 140-459

    Endocrine System 240-279

    Musculoskeletal System 710-739

    Genitourinary System 580-629

    Mental 290-319

    External: Injuries, etc. 800-999

    Respiratory System 460-519

    Digestive System 520-579

    Obstetrical V27

    Cardiovascular 340-459

    Discharges in Millions

    MBD0012E4D4.xls

    Chart9

    1.6

    1.7

    2

    2

    2.4

    3

    3.5

    3.5

    4.1

    6.2

    Discharges in Millions

    Sheet1

    Neoplams 140-4591.61.631

    Endocrine System 240-2791.71.663

    Musculoskeletal System 710-7392.01.969

    Genitourinary System 580-6292.01.974

    Mental 290-3192.42.419

    External: Injuries, etc. 800-9993.02.968

    Respiratory System 460-5193.53.485

    Digestive System 520-5793.53.517

    Obstetrical V274.14.127

    Cardiovascular 340-4596.26.161

    Chart 2-20. Hospital Discharges for the 10 Leading Diagnostic Groups

    United States: 2006

    Hemic and Lymphatic 40-410.40.371

    Urinary System 55-591.01.025

    Nervous System 01-051.21.155

    Respiratory System 30-341.21.167

    Integumentary System 85-861.61.598

    Female Genital Organs 65-712.01.957

    Musculoskeletal 76-844.24.188

    Digestive System 42-545.65.571

    Cardiovascular 35-396.56.491

    Obstetrical 72-757.17.076

    Chart 18-3. Number of Surgical Procedures in the 10 Leading Diagnostic Groups

    United States: 2006

    Sheet1

    1.6

    1.7

    2

    2

    2.4

    3

    3.5

    3.5

    4.1

    6.2

    Discharges in Millions

    Sheet2

    Millions of Discharges

    Hemic and Lymphatic 40-41

    Urinary System 55-59

    Nervous System 01-05

    Respiratory System 30-34

    Integumentary System 85-86

    Female Genital Organs 65-71

    Musculoskeletal 76-84

    Digestive System 42-54

    Cardiovascular 35-39

    Obstetrical 72-75

    0.4

    1

    1.2

    1.2

    1.6

    2

    4.2

    5.6

    6.5

    7.1

    Sheet3

    *

  • Development of Atherosclerotic Plaques

    Normal

    Fatty streak

    Foam cells

    Lipid-rich plaque

    Lipid core

    Fibrous cap

    Thrombus

    Ross R. Nature. 1993;362:801-809.

    *

    2.03

  • PDAY: Percentage of Right Coronary Artery Intimal Surface Affected With Early Atherosclerosis

    PDAY= Pathobiological Determinants of Atherosclerosis in Youth.

    Strong JP, et al. JAMA. 1999;281:727-735.

    Fatty streaks

    Raised lesions

    White

    15-19

    20-24

    25-29

    30-34

    0

    10

    20

    30

    Women

    0

    10

    20

    30

    15-19

    20-24

    25-29

    30-34

    Black

    Age (y)

    0

    10

    20

    30

    White

    15-19

    20-24

    25-29

    30-34

    Men

    Black

    Intimalsurface(%)

    *

  • Most Myocardial Infarctions Are Causedby Low-Grade Stenoses

    Pooled data from 4 studies: Ambrose et al, 1988; Little et al, 1988; Nobuyoshi et al, 1991; and Giroud et al, 1992.(Adapted from Falk et al.)

    Falk E et al, Circulation, 1995.

    *

  • (Adapted from Glagov et al.)

    Coronary Remodeling

    Normal

    vessel

    Minimal

    CAD

    Progression

    Compensatory expansion

    maintains constant lumen

    Expansion overcome:

    lumen narrows

    Severe

    CAD

    Moderate

    CAD

    Glagov et al, N Engl J Med, 1987.

    *

  • Intraluminal thrombus

    Growth of thrombus

    Intraplaque thrombus

    Lipid pool

    Blood Flow

    Atherosclerotic Plaque Rupture and Thrombus Formation

    Adapted from Weissberg PL. Eur Heart J Supplements 1999:1:T1318

    *

    Rupture of atherosclerotic plaque and subsequent thrombosis of the vessel is responsible for the development of acute ischemic coronary syndromes. A lipid-rich core (particularly in the shoulder regions of lesions), abundance of inflammatory cells, a thin fibrous cap and dysfunctional overlying endothelium characterize plaques that are prone to rupture.

    Reference

    Weissberg PL. Eur Heart J Supplements 1999:1:T1318.

  • Eccentric, lipid-richFragile fibrous capPrior luminal obstruction < 50%Visible rupture and thrombus

    Constantinides P. Am J Cardiol. 1990;66:37G-40G.

    Features of a Ruptured Atherosclerotic Plaque

    *

    2.07

  • Libby P. Circulation. 1995;91:2844-2850.

    Vulnerable Plaque

    Thin fibrous capInflammatory cell infiltrates:

    proteolytic activity

    Lipid-rich plaque

    Lumen

    Lipid

    Core

    Fibrous Cap

    Thick fibrous capSmooth muscle cells: more extracellular matrixLipid-poor plaque

    Stable Plaque

    Lumen

    Lipid

    Core

    Fibrous Cap

    Vulnerable Versus Stable Atherosclerotic Plaques

    *

    2.05

  • Correlation of CT angiography of the coronary arteries with intravascular ultrasound illustrates the ability of MDCT to demonstrate calcified and non-calcified coronary plaques (Becker et al., Eur J Radiol 2000)

    Non-calcified, soft, lipid-rich plaque in left anterior descending artery (arrow) (Somatom Sensation 4, 120 ml Imeron 400). The plaque was confirmed by intravascular ultrasound (Kopp et al., Radiology 2004)

    *

  • *

  • Concept of cardiovascular risk factors

    Kannel et al, Ann Intern Med 1961

    Age, sex, hypertension, hyperlipidemia, smoking, diabetes, (family history), (obesity)

  • Major Risk Factors

    Cigarette smoking (passive smoking?)Elevated total or LDL-cholesterolHypertension (BP 140/90 mmHg or on antihypertensive medication)Low HDL cholesterol (
  • Other Recognized Risk Factors

    Obesity: Body Mass Index (BMI)Weight (kg)/height (m2)Weight (lb)/height (in2) x 703 Obesity BMI >30 kg/m2 with overweight defined as 25-40 in. in men, >35 in. in womenPhysical inactivity: most experts recommend at least 30 minutes moderate activity at least 4-5 days/week

    *

  • Prevalence (unadjusted) estimates for poor, intermediate and ideal cardiovascular health

    for each of the 7 metrics of cardiovascular health in the AHA 2020 goals,

    US children aged 12-19 years, NHANES 2007-2008

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Chart1

    16.3432357623083.6567642377

    18.557141708518.958640651362.4842176401

    7.197208724753.851620601138.9511706742

    91.4571719338.5428280670

    4.644661785720.218780189775.1365580246

    2.020390993215.673607204982.3060018019

    1.015740366822.783806840876.2004527924

    Poor

    Intermediate

    Ideal

    Percentage

    Sheet1

    PoorIntermediateIdeal

    Current Smoking16.30.083.7

    Body Mass Index18.619.062.5

    Physical Activity7.253.939.0

    Healthy Diet Score91.58.50.0

    Total Cholesterol4.620.275.1

    Blood Pressure2.015.782.3

    Fasting Plasma Glucose1.022.876.2

  • Age-standardized prevalence for poor, intermediate and ideal cardiovascular health for each of the 7 metrics of cardiovascular health in the AHA 2020 goals,

    among US adults >20 years of age, NHANES 2007-2008

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Chart1

    24.08999792152.972269053172.9377330254

    34.148680074433.991188490431.8601314352

    47.536894565112.98933610739.473769328

    79.047116047520.6916590980.2612248545

    13.998799066939.234183767346.7670171658

    14.189211528841.988455761843.8223327094

    7.92913667840.084754553551.9861087686

    Poor

    Intermediate

    Ideal

    Percentage

    Sheet1

    PoorIntermediateIdeal

    Current Smoking24.13.072.9

    Body Mass Index34.134.031.9

    Physical Activity47.513.039.5

    Healthy Diet Score79.020.70.3

    Total Cholesterol14.039.246.8

    Blood Pressure14.242.043.8

    Fasting Plasma Glucose7.940.152.0

  • Lifetime Risk of Coronary Heart Disease in the Framingham Study

    Men Women

    At age 40 years:48.6%31.7%

    At age 70 years:34.9%24.2%

    Lloyd-Jones et al. Lancet 1999; 353:89-92

    ____________________________________________________________

    ______________________________________________________________

    _________________________________________________________________

    *

  • First Coronary Events: Framingham Study

    Percent as Specified Event

    MyocardialAngina Sudden

    InfarctionPectoris Death

    AgeMen Women Men Women Men Women

    35-64 43%28% 41% 59% 9% 4%

    65-8455%44% 28% 41% 11% 7.4%

    Framingham Study 44 year follow-up.

    ____________________________________________________________

    ________________________________________________________

    ____________________________________________________________

    *

  • Estimated 10-Year CHD Risk in

    55-Year-Old Adults According to Levels of Various Risk Factors

    Framingham Heart Study

    A B C D

    Blood Pressure (mm Hg)120/80140/90140/90140/90

    Total Cholesterol (mg/dL) 200 240 240 240

    HDL Cholesterol (mg/dL) 50 50 40 40

    Diabetes No No Yes Yes

    Cigarettes No No No Yes

    mm Hg = millimeters of mercury

    mg/dL = milligrams per deciliter of blood

    Source:Circulation 1998;97:1837-1847.

    Chart15

    55

    138

    2520

    3727

    Men

    Women

    Estimated 10-Year Rate (%)

    Sheet1

    CVDCVD2001 CVD total mortalityLCD BLACK M/F, 2001LCD AM. INDIAN M/F, 2001AgesMenWomenMenWomenNHES IIINHANES INHANES III

    MalesFemales145,908141,80125-442.02.8A2.61.1Non-Hispanic WhitesNon-Hispanic BlacksMexican AmericansWhite Males163163155% of Men using PA to lose weight% of Men meeting PA guidelines% of Women using PA to lose weight% of Women meeting PA guidelinesNumber of TransplantsEST. COST OF CV DISEASES 2004

    1979500469MALESFEMALESMALESFEMALES45-546.75.5B4.02.0Black Males171165166Whites66.522.863.520.1196823

    80510490Coronary Heart Disease54502,18954CVD+cong.A33.5CVD+cong.A40.1D of H/St.A24.4D of H/St.A25.455-6413.18.4C5.43.5Awareness69.573.957.8White Females170166163Blacks70.122.662.816.9197010Heart Disease238.6

    81500484Stroke18163,53818CancerB22.4CancerB20.8CancerB17.1CancerB19.165-7417.711.1D8.46.3Treatment60.163.040.3Black Females172174168Hispanics63.817.152.714.3197522Coronary Heart Disease133.2

    82495484Congestive Heart Failure652,8286AccidentsC5.9DiabetesF5.1Acc.C14.0Acc.C8.275+18.616.1E14.819.1Control, Treated55.644.644.0Others68.423.063.520.6198057Stroke53.6

    83498494High Blood Pressure546,7655Assault(Homicide)D4.6Nephritis, etc.G2.9C. Liver D.D4.8DiabetesE6.7F22.427.0Control, All Hypertensives33.428.117.7Trends in Mean Total Blood Cholesterol Among Adolescents Ages 12-17 by Sex and Race and Survey1985719Hypertensive Disease55.5

    84491493Diseases of the Arteries439,4044HIV(Aids)E3.7AccidentsC2.8DiabetesE4.3C. Lower res.D.F4.1Prevalence of Coronary Heart Disease by Age and SexNHES III, NHANES I, NHANES III: 1966-70, 1971-74 and 1988-94Leisure-time Physical Activity (PA) Patterns Among Overweight Adults by Race/Ethnicity and Sex19902,107Congestive Heart Failure28.8

    85491498Rheumatic Fever/Rheumatic Heart Disease0.43,4890.4NHANES III: 1988-94Estimated 10 Year Stroke Risk in 55 Year Old AdultsBRFSS: 199819952,363Total CVD*368.4

    86481498Congenital Cardiovascular Defects0.44,1090.4Leading Causes of Death for Black or African American Males and FemalesLeading Causes of Death for American Indian/Alaska Native Males and FemlaesAccording to Levels of Various Risk FactorsExtent of Awareness, Treatment and Control of High Blood Pressure by Race/Ethnicity20002,199

    87475499Other13118,78613United States: 2001United States: 2001Framingham Heart StudyNHANES IV: 1999-200020022,154Estimated Direct and Indirect Costs (in Billions of Dollars) of Cardiovascular Diseases and Stroke

    88476504100.8931,108100.0United States: 2004

    89456486Trend in Heart Transplants

    90448478Percentage Breakdown of Deaths From Cardiovascular DiseasesUnitedStates: 1968-2002

    91447479United States:2001

    92444479

    93457500

    94452498

    95455505

    96453506

    97450503

    98446504

    99446513

    00439507Non-Hispanic WhitesNon-Hispanic BlacksMexican Americans

    01432499YearMalesFemales12% of high school students who participated in vigorous or moderate physical physical activity in past 7 daysMen5.47.68.1

    70779597Whites76.644.218.2Women4.79.511.4

    Cardiovascular Disease Mortality Trends for Males and FemalesMales71851628Blacks26.724.116.4Non-Hispanic White MalesNon-Hispanic White FemalesNon-Hispanic Black MalesNon-Hispanic Black FemalesHispanic MalesHispanic FemalesMalesFemales

    United States: 1979-2001Males72935693ABCDEFCHF PREVALENCEMexican Americans34.317.317.5Vigorous73.759.872.447.868.852.4Non-Hispanic Whites12.45.3Prevalence of Age-Adjusted (2000) Physician-Diagnosed Diabetes in Americans Age 20 and Older by Sex and Race/Ethnicity

    73982725Blood Pressure*95-105138-148138-148138-148138-148138-148MalesFemalesModerate29.824.723.716.525.918.5Non-Hispanic Blacks17.514.6NHANES III: 1988-94 NHANES III

    741030756DiabetesNoNoYesYesYesYes20-240.10.1Prevalence of Current Smoking for Men Ages 18-24 by Education and Race/EthnicityHispanics21.38.8

    751043789Cigarette SmokingNoNoNoYesYesYes25-340.10.1NHANES III: 1988-94Prevalence of Students in Grades 9-12 Who Participated in Sufficient Vigorousu.s. 1979-00

    Prevalence of CVD, U.S. 1988-94 NHANES III761087843Prior AFNoNoNoNoYesYes35-440.70.5or Moderate Physical Activity During the Past 7 Days by Race/Ethnicity and SexPercentage of Overweight Among Students in Grades 9-12 by Sex and Race/EthnicityCatheterizationsOpen-HeartBypassPTCAEndarterectomyPacemakers

    771111852Prior CVDNoNoNoNoNoYes45-541.81.3United States: 2001United States: 200119792991721145442

    AgeMalesFemales78111084455-646.23.4803501971375544

    20-245.54.6791014724* - Closest ranges for women are : 95-104 and 115-124.65-746.86.6814162221597326

    25-3410.44.280104973775+9.89.7824732401708231

    35-4417.413.6811095765MenWomen835122601919525

    45-5434.228.982116084120-349.80.0Prevalence of Congestive Heart Failure by Age and Sex8457627820210339

    55-6451.048.183122985235-4417.116.0NHANES III: 1988-948569030823010740

    65-7465.265.284104484045-5432.330.5867863702848332

    75+70.779.085120584655-6444.153.0878794093321568189

    86125088965-7459.970.38894445735321170120

    Females87126890175+68.884.18999846836824370107

    Prevalence of Cardiovascular Diseases in Americans Age 20 and Older by Age and SexFemales8812208309010465013922666897

    NHANES III :1988-94MenWomen891174819Prevalence of High Blood Pressure in Americans Age 20 and Over by Age and Sex91105751840730367121

    DR FOR WOMEN, CV AND CANCER 2001A55901151795United States: 1999-200092108459046836791113

    LCD HISPANIC M/F, 2001B138911146806WhitesBlacksMexican Americans93107860648536989123

    White FemalesBlack Females63,31747,082C252092124788612

  • Estimated 10-Year Stroke Risk in 55-Year-Old Adults According to Levels of Various Risk Factors Framingham Heart Study

    ABCDEF

    Systolic BP*95-105130-148130-148130-148130-148130-148

    DiabetesNoNoYesYesYesYes

    CigarettesNoNoNoYesYesYes

    Prior Atrial Fib.NoNoNoNoYes Yes

    Prior CVDNoNoNoNoNoYes

    Source: Stroke 1991;22:312-318.

    *BP in millimeters of mercury (mmHg)

    Chart2

    2.61.1

    42

    5.43.5

    8.46.3

    14.819.1

    22.427

    Men

    Women

    Estimated 10-Year Rate (%)

    Sheet1

    CVDCVD2001 CVD total mortalityLCD BLACK M/F, 2001LCD AM. INDIAN M/F, 2001AgesMenWomenMenWomenNHES IIINHANES INHANES III

    MalesFemales145,908141,80125-442.02.8A2.61.1Non-Hispanic WhitesNon-Hispanic BlacksMexican AmericansWhite Males163163155% of Men using PA to lose weight% of Men meeting PA guidelines% of Women using PA to lose weight% of Women meeting PA guidelinesNumber of TransplantsEST. COST OF CV DISEASES 2004

    1979500469MALESFEMALESMALESFEMALES45-546.75.5B4.02.0Black Males171165166Whites66.522.863.520.1196823

    80510490Coronary Heart Disease54502,18954CVD+cong.A33.5CVD+cong.A40.1D of H/St.A24.4D of H/St.A25.455-6413.18.4C5.43.5Awareness69.573.957.8White Females170166163Blacks70.122.662.816.9197010Heart Disease238.6

    81500484Stroke18163,53818CancerB22.4CancerB20.8CancerB17.1CancerB19.165-7417.711.1D8.46.3Treatment60.163.040.3Black Females172174168Hispanics63.817.152.714.3197522Coronary Heart Disease133.2

    82495484Congestive Heart Failure652,8286AccidentsC5.9DiabetesF5.1Acc.C14.0Acc.C8.275+18.616.1E14.819.1Control, Treated55.644.644.0Others68.423.063.520.6198057Stroke53.6

    83498494High Blood Pressure546,7655Assault(Homicide)D4.6Nephritis, etc.G2.9C. Liver D.D4.8DiabetesE6.7F22.427.0Control, All Hypertensives33.428.117.7Trends in Mean Total Blood Cholesterol Among Adolescents Ages 12-17 by Sex and Race and Survey1985719Hypertensive Disease55.5

    84491493Diseases of the Arteries439,4044HIV(Aids)E3.7AccidentsC2.8DiabetesE4.3C. Lower res.D.F4.1Prevalence of Coronary Heart Disease by Age and SexNHES III, NHANES I, NHANES III: 1966-70, 1971-74 and 1988-94Leisure-time Physical Activity (PA) Patterns Among Overweight Adults by Race/Ethnicity and Sex19902,107Congestive Heart Failure28.8

    85491498Rheumatic Fever/Rheumatic Heart Disease0.43,4890.4NHANES III: 1988-94Estimated 10 Year Stroke Risk in 55 Year Old AdultsBRFSS: 199819952,363Total CVD*368.4

    86481498Congenital Cardiovascular Defects0.44,1090.4Leading Causes of Death for Black or African American Males and FemalesLeading Causes of Death for American Indian/Alaska Native Males and FemlaesAccording to Levels of Various Risk FactorsExtent of Awareness, Treatment and Control of High Blood Pressure by Race/Ethnicity20002,199

    87475499Other13118,78613United States: 2001United States: 2001Framingham Heart StudyNHANES IV: 1999-200020022,154Estimated Direct and Indirect Costs (in Billions of Dollars) of Cardiovascular Diseases and Stroke

    88476504100.8931,108100.0United States: 2004

    89456486Trend in Heart Transplants

    90448478Percentage Breakdown of Deaths From Cardiovascular DiseasesUnitedStates: 1968-2002

    91447479United States:2001

    92444479

    93457500

    94452498

    95455505

    96453506

    97450503

    98446504

    99446513

    00439507Non-Hispanic WhitesNon-Hispanic BlacksMexican Americans

    01432499YearMalesFemales12% of high school students who participated in vigorous or moderate physical physical activity in past 7 daysMen5.47.68.1

    70779597Whites76.644.218.2Women4.79.511.4

    Cardiovascular Disease Mortality Trends for Males and FemalesMales71851628Blacks26.724.116.4Non-Hispanic White MalesNon-Hispanic White FemalesNon-Hispanic Black MalesNon-Hispanic Black FemalesHispanic MalesHispanic FemalesMalesFemales

    United States: 1979-2001Males72935693ABCDEFCHF PREVALENCEMexican Americans34.317.317.5Vigorous73.759.872.447.868.852.4Non-Hispanic Whites12.45.3Prevalence of Age-Adjusted (2000) Physician-Diagnosed Diabetes in Americans Age 20 and Older by Sex and Race/Ethnicity

    73982725Blood Pressure*95-105138-148138-148138-148138-148138-148MalesFemalesModerate29.824.723.716.525.918.5Non-Hispanic Blacks17.514.6NHANES III: 1988-94 NHANES III

    741030756DiabetesNoNoYesYesYesYes20-240.10.1Prevalence of Current Smoking for Men Ages 18-24 by Education and Race/EthnicityHispanics21.38.8

    751043789Cigarette SmokingNoNoNoYesYesYes25-340.10.1NHANES III: 1988-94Prevalence of Students in Grades 9-12 Who Participated in Sufficient Vigorousu.s. 1979-00

    Prevalence of CVD, U.S. 1988-94 NHANES III761087843Prior AFNoNoNoNoYesYes35-440.70.5or Moderate Physical Activity During the Past 7 Days by Race/Ethnicity and SexPercentage of Overweight Among Students in Grades 9-12 by Sex and Race/EthnicityCatheterizationsOpen-HeartBypassPTCAEndarterectomyPacemakers

    771111852Prior CVDNoNoNoNoNoYes45-541.81.3United States: 2001United States: 200119792991721145442

    AgeMalesFemales78111084455-646.23.4803501971375544

    20-245.54.6791014724* - Closest ranges for women are : 95-104 and 115-124.65-746.86.6814162221597326

    25-3410.44.280104973775+9.89.7824732401708231

    35-4417.413.6811095765MenWomen835122601919525

    45-5434.228.982116084120-349.80.0Prevalence of Congestive Heart Failure by Age and Sex8457627820210339

    55-6451.048.183122985235-4417.116.0NHANES III: 1988-948569030823010740

    65-7465.265.284104484045-5432.330.5867863702848332

    75+70.779.085120584655-6444.153.0878794093321568189

    86125088965-7459.970.38894445735321170120

    Females87126890175+68.884.18999846836824370107

    Prevalence of Cardiovascular Diseases in Americans Age 20 and Older by Age and SexFemales8812208309010465013922666897

    NHANES III :1988-94MenWomen891174819Prevalence of High Blood Pressure in Americans Age 20 and Over by Age and Sex91105751840730367121

    DR FOR WOMEN, CV AND CANCER 2001A55901151795United States: 1999-200092108459046836791113

    LCD HISPANIC M/F, 2001B138911146806WhitesBlacksMexican Americans93107860648536989123

    White FemalesBlack Females63,31747,082C252092124788612

  • Offspring CVD Risk by Parental CVD Status: Framingham Study

    Risk Ratio

    2.5

    2

    1.5

    1

    0.5

    0

    Men

    Women

    1.0

    1.7

    2.2

    1.0

    1.7

    1.7

    Adjusted for: age, total/HDL Chol. ratio, SBP, smoking, diabetes, BMI

    Parental CVD

  • Multivariable Risk

    Risk imposed by a strong family history of heart attacks varies widely depending on the burden of modifiable risk factors

    *

  • 9

    Doubts about cholesterol as late as 1989

    *

  • Lifetime Risk of CHD Increases with Serum Cholesterol

    Framingham Study: Subjects age 40 years

    DM Lloyd-Jones et al Arch Intern Med 2003; 1966-1972

    34

    44

    57

    19

    29

    33

    Cholesterol

    ___________________________________________________________________________

    _______________________________________________________________________________

    *

  • Q = serum cholesterol quintile.

    Kannel WB et al. Am Heart J. 1986;112:825-836.

    Multiple Risk Factor Intervention Trial (MRFIT) N=325,346

    Correlation Between Serum Cholesterol and CVD Mortality

    6-Year CVD Death Rate Per 1000

    0

    5

    10

    15

    20

    25

    30

    Q1

    (244)

    35-39 years

    40-44 years

    45-49 years

    50-54 years

    55-57 years

    Serum Cholesterol Quintile (mg/dL)

    Untreated Patients

    *

  • Source: NCHS and NHLBI. NH indicates non-Hispanic. Mex. Am. indicates Mexican American.

    * Data for Mexican Americans not available.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

    Trends in mean total serum cholesterol among adolescents 1217 years of age by race, sex, and survey year (NHANES: 19881994*, 19992004 and 2005-2008).

  • Source: NCHS and NHLBI. NH indicates non-Hispanic.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

    Trends in mean total serum cholesterol among adults ages 20 by race and survey year, (NHANES: 19881994, 19992004 and 20052008).

  • *

  • CK Friedberg on Hypertension: Diseases of the Heart 1996

    There is a lack of correlation in most cases between the severity and duration of hypertension and development of cardiac complications.

    ___________________________________________________________

    ________________________________________________________

    _______________________________________________________________

    *

  • *

  • *

  • Relation of Non-Hypertensive Blood Pressure to Cardiovascular DiseaseVasan R, et al. N Engl J Med 2001; 345:1291-1297

    10-year Age- Adjusted Cumulative Incidence

    Hazard Ratio*

    SBPWomenMen

  • Source: NCHS and NHLBI. Hypertension is defined as SBP 140 mm Hg or DBP 90 mmHg, taking antihypertensive medication, or being told twice by a physician or other professional that one has hypertension.

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Prevalence of High Blood Pressure in adults 20 years of age by age and sex (NHANES: 20052008)

  • Extent of awareness, treatment and control of high blood pressure by race/ethnicity (NHANES : 2005-2006).

    Source: NCHS and NHLBI.

    Chart1

    78.87982.367.6

    69.170.174.752.1

    45.446.146.535.2

    Total Population

    NH Whites

    NH Blacks

    Mexican Americans

    Percent of Population With Hypertension

    OVERWT

    1960-621971-741976-801988-942001-2004

    Men10.712.212.820.630.2

    Women15.716.817.126.034.0

    Age-Adjusted Prevalence of Obesity* in Adults Ages 20-74 by Sex and Survey

    NHES and NHANES: 1960--62, 1971--74, 1976--80, 1988--94 and 2001-2004

    Source:Health US, 2007

    Obesity is defined as BMI of 30 plus.

    &A

    Page &P

    OVERWT

    1960-62

    1971-74

    1976-80

    1988-94

    2001-2004

    Percent of Population

    cholchild

    Trends in Mean Total Blood Cholesterol Among Adolescents Ages 12-17 by Sex and Race and Survey

    NHANES:1976-80,1988-94, 1999-02, 2003-04 and 2005-06

    1976-801988-941999-022003-042005-06

    White Males163163155156151

    Black Males171165166161161

    White Females170166163164163

    Black Females172174168161160

    Mex. Am. Males157158

    Mex. Am. Females158161

    cholchild

    11

    &A

    Page &P

    #REF!

    #REF!

    Percent of Population

    diabetes

    NH WhitesNH BlacksMexican Americans

    Men5.814.911.3

    Women6.113.114.2

    Age-Adjusted Prevalence of Physician-Diagnosed Diabetes in Adults Age 20 and Older by Sex and Race/Ethnicity

    NHANES: 2005-2006

    NH WhitesNH BlacksMexican Americans

    Less than high school8.115.313.0

    High school6.117.512.2

    More than high school5.410.812.0

    Prevalence of Physician Diagnosed Type 2 Diabetes in Americans Age 18+

    by Education, Race/Ethnicity and Years of Education

    NHANES: 2005-2006

    `

    NCHS and NHLBI.

    MaleFemale

    Physician diagnosed 1988-945.45.4

    Undiagnosed 1988-943.42.5

    Physician diagnosed 2005-067.48.0

    Undiagnosed 2005-063.82.1

    Trends in Diabetes Prevalence in Adults Age 20 and Older, By Sex

    NHANES: 1988-94 and 2005-2006

    Source: NCHS and NHLBI.

    1976-80

    1988-94

    1999-02

    2003-04

    2005-06

    Mean Total Blood Cholesterol

    &A

    Page &P

    diabetes

    NH Whites

    NH Blacks

    Mexican Americans

    Percent of Population

    Hdl&Ldl

    Estiamted % of Americans Age 20 and Over with High-Risk LDL-Cholesterol of 130 mg/dL or More by Race and Sex

    MenWomen

    Total Population32.032.0

    NH Whites32.034.0

    NH Blacks32.030.0

    Mexican Americans39.031.0

    Age-Adjusted Prevalence of Americans Age 20 and Older With

    LDL-Cholesterol of 130 mg/dL or Higher by Race/Ethnicity and Sex

    United States: 2003-04

    MenWomen

    Total259

    NH Whites269

    NH Blacks167

    Mexican Americans2813

    Estimated Age-Adjusted (2000) Prevalence of Adults Age 20 and Over With

    HDL-Cholesterol Under 40 mg/dL by Race and Sex

    United States: NHANES 2003-2004

    Less than high school

    High school

    More than high school

    Percent of Population

    Male

    Female

    Percent of Population

    Hdl&Ldl

    Men

    Women

    Percent of Population

    smokhschool

    `NH WhitesNH BlacksHispanics

    Males23.814.918.7

    Females22.58.414.6

    Prevalence of High School Students in Grades 9-12 Reporting Current Cigarette Use

    Within the last 30 days by Race/Ethnicity and Sex

    YRBS: 2007

    Men

    Women

    Percent of Population

    &A

    Page &P

    smokhschool

    Males

    Females

    Percent of Population

    Metsyndr.

    CHD MortalityCVD MortalityTotal Mortality

    No MetS or DM2.65.314.4

    MetS w/o DM4.37.817.1

    MetS w/DM4.88.621.1

    DM only6.311.526.1

    Prior CVD10.916.730.0

    Prior CVD and DM17.028.144.1

    Total Mortality Rates in US Adults Age 30-75, with Metabolic Syndrome, With and Without Diabetes and Pre-Existing CVD

    NHANES1976-80 Follow-Up Study

    Metsyndr.

    No MetS or DM

    MetS w/o DM

    MetS w/DM

    DM only

    Prior CVD

    Prior CVD and DM

    Deaths/1,000 Person Years

    PhysicAct.

    NH WhiteNH BlackHispanic

    Male46.141.338.6

    Female27.921.021.9

    Prevalence of Students in Grades 9-12 Who Met Currently Recommended Levels of

    Physical Activity During the Past 7 Days by Race/Ethnicity and Sex

    YRBS: 2007Centers for disease control and Prevention. Youth risk Behavior Surveillance - United States, 2007. MMWR 2008;57(ss#4)

    Men '01Women '01Men '05Women '05

    NH White50.646.052.349.6

    NH Black40.331.445.336.1

    Hispanic42.036.341.940.5

    Other race43.141.245.746.6

    Prevalence of Leisure-Time Physical Activity Among Adults Age 18+ by Race/Ethnicity, and Sex

    BRFSS: 2001, 2005

    MMWR, vol.56, no.46, 11/23/07.

    NH WhiteNH BlackHispanic

    Male16.721.818.8

    Female28.242.135.2

    Prevalence of Students in Grades 9-12 Who Did Not Meet Currently Recommended Levels of

    Moderate-to-Vigorous Physical Activity During the Past 7 Days by Race/Ethnicity and Sex

    YRBS: 2007"Currently recommended levels" are defined as activity that increases heart rates and made them breathe hard some of the time for a total of >60 or more minutes/day on >5 or more out of 7 days predeeding the survey.

    6-1112-1516-19

    Male48.911.910.020-2930-3940-4950-5960-6970+

    Female34.73.45.4Male10.39.99.37.16.53.5

    Female7.46.56.65.75.82.2

    Prevalence of Children Ages 6-19 Who Attained sufficient MVPA to Meet Public Health Recommendations of >60 or More

    Minutes/Day on >5 or more of 7 Days by Sex and AgeMean Minutes/Day of MVPA in Bouts of 10+ Minutes by Sex and Age

    NHANES 2003-2004

    Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical Activity in the United States Measured by Accerometer. MSSE 2008; 40: 181-188.

    Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical Activity in the United States Measured by Accerometer. MSSE 2008; 40: 181-188.

    &A

    Page &P

    PhysicAct.

    NH White

    NH Black

    Hispanic

    Percent of Population

    smokmf

    1212

    Under 89-111213-1516 and UpWhites76.644.218.2Whites60.649.120.1

    Men27.739.731.526.611.5Blacks26.724.116.4Blacks34.314.112.8

    Women16.734.324.122.811.2Mexican Americans34.317.317.5Mexican Americans12.219.510.3

    Prevalence of Current Smoking for Men Ages 18-24 by Education and Race/EthnicityPrevalence of Current Smoking for Women Ages 18-24 by Education and Race/Ethnicity

    Current Cigarette Smoking for Adults Age 18 and Over by Education and SexUnited States: 1988-94United States: 1988-94

    United States: 1998

    Non-Hispanic White MenNon-Hispanic White WomenNon-Hispanic Black MenNon-Hispanic Black WomenHispanic MenHispanic WomenMenWomen

  • CK Friedberg on HypertensionDiseases of the Heart 1966

    Hypertension imposes a load on the heart which for many years may be compensated by left ventricular hypertrophy

    _______________________________________________________________

    _______________________________________________________________

    *

  • CVD Risk Imposed by ECG-LVH Framingham Study 36-yr. Follow-up

    Age-adjusted Risk Excess Risk

    Rate per 1000 Ratio per 1000

    Age Men Women Men Women Men Women

    35-64 164 135 4.7*** 7.4*** 129 117

    65-94 234 235 2.8*** 4.1*** 51 178

    Biennial Rate per 1000. CVD=CHD, stroke, peripheral vascular disease, heart failure***P

  • Smoking Statement Issued in 1956 by American Heart Association

    It is the belief of the committee that much greater knowledge is needed before any conclusions can be drawn concerning relationships between smoking and death rates from coronary heart disease. The acquisition of such knowledge may well require the use of techniques and research methods that have not hitherto been applied to this problem.

    Circulation 1960; vol. 23

    ___________________________________________________________

    ____________________________________________________________

    ___________________________________________________________

    *

  • CHD Risk by Cigarette Smoking. Filter Vs. Non-filter. Framingham Study. Men

  • Source: MMWR Surveill Summ. 2010;59:1142.NH indicates non-Hispanic.

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Prevalence of students in grades 9 to 12 reporting current cigarette use by sex and race/ethnicity (YRBSS, 2009)

  • All percentages are age-adjusted. NH indicates non-Hispanic. *Includes both Hispanics and non-Hispanics. Data derived from Centers for Disease Control and Prevention/National Center for Health Statistics, Health Data Interactive.

    2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Prevalence of current smoking for adults > 18 years of age by race/ethnicity and sex (NHIS: 2007-2009)

  • Source: CDC/NCHS, Health Data Interactive. All percentages are age-adjusted. NH indicates non-Hispanic.

    * Includes both Hispanics and non-Hispanics.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

    Prevalence of current smoking for adults > 18 years of age by race/ethnicity and sex (NHIS: 2006-2008)

  • Diseases of The HeartCharles K Friedberg MD, WB Saunders Co. Philadelphia, 1949

    The proper control of diabetes is obviously desirable even though there is uncertainty as to whether coronary atherosclerosis is more frequent or severe in the uncontrolled diabetic

    ________________________________________________________________

    ______________________________________________________________

    *

  • Risk of Cardiovascular Events in Diabetics Framingham Study

    Age-adjusted

    Biennial Rate Age-adjusted

    Per 1000 Risk Ratio

    Cardiovascular Event Men Women Men Women

    Coronary Disease 39 21 1.5** 2.2***

    Stroke15 6 2.9*** 2.6***

    Peripheral Artery Dis. 18 18 3.4*** 6.4***

    Cardiac Failure 23 21 4.4*** 7.8***

    All CVD Events 76 65 2.2*** 3.7***

    Subjects 35-64 36-year Follow-up **P

  • Source: NCHS and NHLBI. NH indicates non-Hispanic.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

    Age-adjusted prevalence of physician-diagnosed diabetes in adults 20 years of age by race/ethnicity and sex (NHANES: 20052008).

  • Source: NCHS, NHLBI.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

    Trends in diabetes prevalence in adults 20 years of age, by sex (NHANES: 19881994 and 20052008).

  • *

  • Skepticism About Importance of Obesity

    Keys A, Aravanis C, Blackburn H, et al. Ann Intern Med 1972; 77:15-27.

    Concluded that all the excess risk of coronary heart disease in the obese derives from its atherogenic accompaniments, illogically leaving the impression that obesity is therefore unimportant.

    Mann GV. N Engl J Med 1974; 291:226-232.

    The contribution of obesity to CHD is either small or non-existent. It cannot be expected that treating obesity is either logical or a promising approach to the management of CHD.

    Barrett-Connor EL. Ann Intern Med 1985; 103:1010-1019

    NIH consensus panel is equivocal about the role of obesity as a cause of CHD.

    *

  • Relation of Weight Change to Changes in

    Atherogenic Traits: The Framingham Study

    Frantz Ashley, Jr. and William B Kannel

    J Chronic Dis 1974

    Weight gain is accompanied by atherogenic alterations in blood lipids, blood pressure, uric acid and carbohydrate tolerance.

    It seems reasonable to expect that correction of overweight will improve the coronary risk problem.

    Avoidance of overweight would seem a desirable goal in the general population if the appalling annual toll from disease is to be substantially reduced.

    *

  • 2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Trends in the prevalence of obesity among US children and adolescents by age and survey year (National Health and Nutrition Examination Survey: 1971-1974, 1976-1980, 1988-1994, 1999-2002 and 20052008)

    Data derived from Health, United States, 2010: With Special Feature on Death and Dying. NCHS, 2011.

  • 2011 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2011

    Data derived from Health, United States, 2010: With Special Feature on Death and Dying. NCHS, 2011.

    Age-adjusted prevalence of obesity in adults 2074 years of age, by sex and survey year (NHES: 196062; NHANES: 197174, 197680, 198894, 1999-2002 and 2005-08)

  • 3

    2.4

    1.8

    1.2

    0.6

    0

    Q1Q2Q3Q4Q5Overall

    Thin

    Obese

    Risk Factor Sum and Obesity

    (1971-74) and (1989-93)

    Risk Factor Sum

    Risk variables include bottom quintile for HDL-C and top quintiles for cholesterol, SBP, triglycerides and glucose

    Wilson PWF, & Kannel WB Nutr Clin Care 1999; 1:44-50

    Framingham Study

    Risk factors accumulate with weight gain

    *

  • Currently recommended levels is defined as activity that increased their heart rate and made them breathe hard some of the time for a total of at least 60 minutes per day on 5 of the 7 days preceding the survey. Source: MMWR Surveillance Summaries.1 NH indicates non-Hispanic.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

    Prevalence of students in grades 912 who met currently recommended levels of PA during the past 7 days by race/ethnicity and sex (YRBS: 2009).

  • Source: Pleis et al, 2010. NH indicates non-Hispanic. Percents are age-adjusted. Regular leisure-time physical activity is defined as 3 or more sessions

    per week of vigorous activity lasting at least 20 minutes or five or more sessions per week of light/moderate activity lasting at least 30 minutes.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

    Prevalence of regular leisure-time physical activity among adults > 18 years of age by race/ethnicity and sex (NHIS: 2009).

  • Prevalence of students in grades 9 to 12 reporting current cigarette use

    by sex and race/ethnicity (YRBSS, 2009).

    Source: MMWR Surveill Summ. 2010;59:1142.NH indicates non-Hispanic.

    2010 American Heart Association, Inc. All rights reserved.

    Roger VL et al. Published online in Circulation Dec. 15, 2010

  • *

  • Risk Assessment

    Count major risk factors

    For patients with multiple (2+) risk factorsPerform 10-year risk assessmentFor patients with 01 risk factor10 year risk assessment not requiredMost patients have 10-year risk
  • ATP III Assessment of CHD Risk

    For persons without known CHD, other forms of atherosclerotic disease, or diabetes:

    Count the number of risk factors:Cigarette smokingHypertension (BP 140/90 mmHg or on antihypertensive medication)Low HDL cholesterol (
  • Note: Risk estimates were derived from the experience of the Framingham Heart Study, a predominantly Caucasian population in Massachusetts, USA.

    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486-2497.

    Assessing CHD Risk in Men

    Step 2: Total Cholesterol

    TC Points atPoints atPoints atPoints atPoints at(mg/dL) Age 20-39Age 40-49Age 50-59Age 60-69Age 70-79

  • Point Total10-Year RiskPoint Total10-Year Risk

  • Step 1: Age

    Expert Panel on Detection, Evaluation, and Treatment of High BloodCholesterol in Adults. JAMA. 2001;285:2486-2497.

    ATP III Framingham Risk Scoring

    2001, Professional Postgraduate Services

    www.lipidhealth.org

    *

  • Step 2: Total Cholesterol

    Note: TC and HDL-C values should be the average of at least two fasting lipoprotein measurements.

    Expert Panel on Detection, Evaluation, and Treatment of High BloodCholesterol in Adults. JAMA. 2001;285:2486-2497.

    Men

    TC Points atPoints atPoints atPoints atPoints at(mg/dL) Age 20-39Age 40-49Age 50-59Age 60-69Age 70-79

  • Step 3: HDL-Cholesterol

    Note: HDL-C and TC values should be the average of at least two fasting lipoprotein measurements.

    Expert Panel on Detection, Evaluation, and Treatment of High BloodCholesterol in Adults. JAMA. 2001;285:2486-2497.

    Men

    Women

    ATP III Framingham Risk Scoring

    2001, Professional Postgraduate Services

    www.lipidhealth.org

    *

  • Step 4: Systolic Blood Pressure

    Note: The average of several BP measurements is needed for an accuratemeasurement of baseline BP. If an individual is on antihypertensive treatment,extra points are added.

    Expert Panel on Detection, Evaluation, and Treatment of High BloodCholesterol in Adults. JAMA. 2001;285:2486-2497.

    ATP III Framingham Risk Scoring

    2001, Professional Postgraduate Services

    www.lipidhealth.org

    *

  • Step 5: Smoking Status

    Note: Any cigarette smoking in the past month.

    Expert Panel on Detection, Evaluation, and Treatment of High BloodCholesterol in Adults. JAMA. 2001;285:2486-2497.

    ATP III Framingham Risk Scoring

    2001, Professional Postgraduate Services

    www.lipidhealth.org

    *

  • Step 6: Adding Up the Points(Sum From Steps 15)

    Expert Panel on Detection, Evaluation, and Treatment of High BloodCholesterol in Adults. JAMA. 2001;285:2486-2497.

    ATP III Framingham Risk Scoring

    2001, Professional Postgraduate Services

    www.lipidhealth.org

    *

  • Step 7: CHD Risk for Men

    Note: Determine the 10-year absolute risk for hard CHD (MI and coronary death) from point total.

    Expert Panel on Detection, Evaluation, and Treatment of High BloodCholesterol in Adults. JAMA. 2001;285:2486-2497.

    ATP III Framingham Risk Scoring

    2001, Professional Postgraduate Services

    www.lipidhealth.org

    *

  • Presentation

    Examination:Height: 6 ft 2 inWeight: 220 lb (BMI 28 kg/m2)Waist circumference: 41 inBP: 150/88 mm HgP: 64 bpm RR: 12 breaths/minCardiopulmonary exam: normalLaboratory results: TC: 220 mg/dLHDL-C: 36 mg/dLLDL-C: 140 mg/dLTG: 220 mg/dLFBS: 120 mg/dL

    *

  • What is WJCs 10-year absolute riskof fatal/nonfatal MI?

    A 12% absolute risk is derived from points assigned in Framingham Risk Scoring to:Age: 6TC: 3HDL-C: 2SBP: 2Total: 13 points

    In 1992 he exercised 14 minutes in a Bruce protocol exercise stress test to 91% of his maximum predicted heart rate without any abnormal ECG changes. He started on a statin in 2001. But in Sept 2004, he needed urgent coronary bypass surgery.

    *

  • Step 7: CHD Risk for Women

    Note: Determine the 10-year absolute risk for hard CHD (MI and coronary death) from point total.

    Expert Panel on Detection, Evaluation, and Treatment of High BloodCholesterol in Adults. JAMA. 2001;285:2486-2497.

    ATP III Framingham Risk Scoring

    2001, Professional Postgraduate Services

    www.lipidhealth.org

    *

  • CHD Risk Equivalents

    Risk for major coronary events equal to that in established CHD10-year risk for hard CHD >20%

    Hard CHD = myocardial infarction + coronary death

    *

  • Diabetes as a CHD Risk Equivalent

    10-year risk for CHD 20%High mortality with established CHDHigh mortality with acute MIHigh mortality post acute MI

    *

  • CHD Risk Equivalents

    Other clinical forms of atherosclerotic disease (peripheral arterial disease, abdominal aortic aneurysm, and symptomatic carotid artery disease)DiabetesMultiple risk factors that confer a 10-year risk for CHD >20%

    *

  • Framingham 10-year Total CVD Risk Algorithm (DAgostino et al 2008)

  • International Comparisons in CVD Morbidity and Mortality

    CVD accounts for 25-45% of deaths among different countriesCVD death rates (per 100,000) range from 1310 in Russia to 201 in Japan (6.5 fold difference) in men and from 581 in Russia to 84 in France (7-fold difference)USA ranks 16th for both men (413) and women (201)

    *

  • Secular Trends in CHD and Stroke Mortality

    From 1985-1992, greatest annual decline (6-7%) in CHD seen in Israel among men and France among women, USA intermediate (4%), increases in Poland and Romania.Stroke death rates declined most in Australia, Italy, and France (8-9%), USA about 3%.

    *

  • Age-Adjusted Death Rates for Coronary Heart Disease by Country and Sex, Ages 35-74, 1999

    Age-Adjusted to European StandardData for 1999 unless noted

    Source: NHLBI 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases

    *

  • Age-Adjusted Death Rates for Stroke by Country and Sex, Ages 35-74, 1999

    Age-Adjusted to European StandardData for 1999 unless noted

    Source: NHLBI 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases

    *

  • Change in Age-Adjusted Death Rates for Coronary Heart Disease by Country and Sex, Ages 35-74, 1990-1999

    Age-Adjusted to European StandardLatest data year note in parentheses

    Source: NHLBI 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases

    Men

    Women

    *

  • Change in Age-Adjusted Death Rates for Stroke by Country and Sex, Ages 35-74, 1990-1999

    Age-Adjusted to European StandardLatest data year note in parentheses

    Source: NHLBI 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases

    Men

    Women

    *

  • Migrant Studies

    Ni-Hon-San Study showed Japanese living in Japan to have the lowest cholesterol levels and lowest rates of CHD, those living in Hawaii to have intermediate rates for both, and those living in San Francisco to have the highest cholesterol levels and CHD incidence

    *

  • Pyramid of Risk (Werner et al. Canadian Journal of Cardiology 1998; 14(Suppl) B:3B-10B)

    *

  • Approaches to Primary and Secondary Prevention of CVD

    Primary prevention involves prevention of onset of disease in persons without symptoms.Primordial prevention involves the prevention of risk factors causative o the disease, thereby reducing the likelihood of development of the disease.Secondary prevention refers to the prevention of death or recurrence of disease in those who are already symptomatic

    *

  • Risk Factor Concepts in Primary Prevention

    Nonmodifiable risk factors include age, sexc, race, and family history of CVD, which can identify high-risk populationsBehavioral risk factors include sedentary lifestyle, unhealthful diet, heavy alcohol or cigarette consumption.Physiological risk factors include hypertension, obesity, lipid problems, and diabetes, which may be a consequence of behavioral risk factors.

    *

  • Population vs. High-Risk Approach

    Risk factors, such as cholesterol or blood pressure, have a wide bell-shaped distribution, often with a tail of high values.The high-risk approach involves identification and intensive treatment of those at the high end of the tail, often at greatest risk of CVD, reducing levels to normal.But most cases of CVD do not occur among the highest levels of a given risk factor, and in fact, occur among those in the average risk group.Significant reduction in the population burden of CVD can occur only from a population approach shifting the entire population distribution to lower levels.

    *

  • Expected Shifts in Cholesterol Distribution from High-Risk, Population, and Combined Approaches

    *

  • Population and Community-Wide CVD Risk Reduction Approaches

    Populations with high rates of CVD are those with Western lifestyles of high-fat diets, physical inactivity, and tobacco use.Targets of a population-wide approach must be these behaviors causative of the physiologic risk factors or directly causative of CVD.Requires public health services such as surveillance (e.g.,BFRSS), education (AHA, NCEP), organizational partnerships (Singapore Declaration), and legislation/policy (Anti-Tobacco policies)Activities in a variety of community settings: schools, worksites, churches, healthcare facilities, entire communities

    *

  • A conceptual framework for public health practice in CVD prevention. (From Pearson et al., J Public Health. 2001; 29:69 78)

    *

  • Communitywide CVD Prevention Programs

    Stanford 3-Community Study (1972-75) showed mass media vs. no intervention in high-risk residents to result in 23% reduction in CHD risk scoreNorth Karelia (1972-) showed public education campaign to reduce smoking, fat consumption, blood pressure, and cholesterolStanford 5-City Project (1980-86) showed reductions in smoking, cholesterol, BP, and CHD riskMinnesota Heart Health Program (1980-88) showed some increases in physical activity and in women reductions in smoking

    *

  • Materials Developed for US Community Intervention Trials

    Mass media, brochures and direct mailEvents and contestsScreeningsGroup and direct educationSchool programs and worksite interventionsPhysician and medical setting programsGrocery store and restaurant projectsChurch interventionsPolicies

    *

  • Individual and High-Risk Approaches

    Primary Prevention Guidelines (1995) and Secondary Prevention Guidelines (Revised 2001) released by the American Heart Association provide advice regarding risk factor assessment, lifestyle modification, and pharmacologic interventions for specific risk factorsBarriers exist in the community and healthcare setting that prevent efficient risk reductionSurveys of CVD prevention-related services show disappointing results regarding cholesterol-lowering therapy, smoking cessation, and other measures of risk reduction

    *

    *

    *

    *

    *

    *

    Hospital Specialty_FINAL ATS

    *

    *

    *

    *

    *

    *

    2.03

    *

    *

    *

    *

    Rupture of atherosclerotic plaque and subsequent thrombosis of the vessel is responsible for the development of acute ischemic coronary syndromes. A lipid-rich core (particularly in the shoulder regions of lesions), abundance of inflammatory cells, a thin fibrous cap and dysfunctional overlying endothelium characterize plaques that are prone to rupture.

    Reference

    Weissberg PL. Eur Heart J Supplements 1999:1:T1318.

    *

    2.07

    *

    2.05

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *